Cook Research
CompanyUnited StatesFounded 1983
Cook Research develops 2 assets, the furthest in human trials (Evero DCB in peripheral arterial disease). Mostly device acting on mTOR signalling and MTOR; based in the United States, founded in 1983.
- 2
- Assets
- Furthest stage
- Human trials
- 2
- Trials
- 1
- Signal
Pipeline
2Delivers everolimus locally to inhibit mTOR and vascular smooth muscle proliferation, limiting restenosis after angioplasty.
Human trials, Device, mTOR signalling, MTOR, peripheral arterial disease, peripheral vascular disease
Zenith Fenestrated+ Endovascular Graft
Endovascular stent graft for endovascular aneurysm repair to exclude aortic aneurysms involving visceral arteries.
Human trials, Device, abdominal aortic aneurysm, extent IV thoracoabdominal
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms2
- Trials2
- Signals1
- Similar companies6